Amneal Pharmaceuticals Announces Launch Of Esomeprazole Strontium 49.3 Mg Delayed-Release Capsules Authorized Generic
1/6/2014 9:57:15 AM
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals LLC today announced the launch of generic Esomeprazole strontium delayed-release capsules 49.3 mg. This new esomeprazole therapy is the generic equivalent of the recently launched brand Esomeprazole strontium. It contains the same active moiety (esomeprazole) in a different salt form as found in the leading PPI brand Nexium® (esomeprazole magnesium) and presents a potentially more affordable treatment option for GERD in adult patients.
Help employers find you! Check out all the jobs and post your resume.
comments powered by